Saturday 17 October 2026
Export JBS’s income statement to Excel — free account
JBS N.V.
JBS Consumer Defensive Packaged Foods
JBS N.V.’s revenue for fiscal 2025 (year ended December 2025) was $86.2 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS fell 120.8%, free cash flow grew 238.9% and total debt rose 15.1%, each against the same quarter a year earlier.
13.03
0.31
+2.44%
Follow JBS
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
7.19 | 7.55 |
Altman Z-Score |
— | 2.72 |
P/S ratio |
0.00 | 0.18 |
Altman Z″-Score (non-manufacturers) |
— | 2.05 |
P/FCF ratio |
7.43 | 17.14 |
Beneish M-Score |
— | (2.28) |
P/Operating CF |
(26.78) | 7.96 |
P/B ratio |
1.83 | 1.62 |
Price to Tangible BV |
1.83 | 8.35 |
EV/Sales |
0.00 | 0.39 |
EV/EBITDA |
0.00 | 5.13 |
EV/Operating CF |
8.12 | 11.32 |
EV/FCF |
14.92 | 36.92 |
Quick Ratio |
0.87 | 0.86 |
Current Ratio |
1.47 | 1.60 |
Net Debt/EBITDA |
2.28 | 2.75 |
Debt/Assets |
50.94% | 49.83% |
Debt/Equity |
2.55 | 2.36 |
Asset Turnover |
0.00 | 2.01 |
Operating CF/Net income |
2.39 | 1.45 |
Capex/Depreciation |
(0.66) | (0.88) |
Interest Coverage |
1.83 | 1.96 |
| 0.00% | 22.93% | |
| 0.00% | 4.72% | |
ROIC |
11.84% | 9.52% |
Return on Tangible Assets |
10.25% | 9.85% |
Average Days of Receivables |
20.68 | 21.98 |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.21% | 8.33% |
Intangible Assets out of Total Assets |
0.18 | 0.17 |
Share Based Compensation of Revenue |
0.02% | 0.03% |
Graham Net Nets |
(1.04) | (1.12) |
Graham Number |
0.00 | 19.57 |
Earnings Yield |
13.90% | 13.24% |
Free Cash Flow Yield |
13.46% | 5.83% |
Revenue per Share |
72.23 | 80.66 |
Operating CF per Share |
3.96 | 2.74 |
Capex per Share |
(1.35) | (1.90) |
Free Cash Flow per Share |
2.61 | 0.84 |
Cash per Share |
5.38 | 4.42 |
Shareholders Equity per Share |
7.61 | 8.91 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
7.61 | 8.91 |
Free Cash Flow |
2,785.88 | 898.76 |
Working Capital |
5,463.95 | 6,896.39 |
Capital Expenditures |
(1,443.67) | (2,033.19) |
Net Current Asset Value |
(15,429.99) | (17,195.50) |
EV/EBIT |
0.00 | 7.98 |
Capex to Sales |
0.02 | 0.02 |
Price to Operating Income |
0.00 | 3.70 |
| Other line items | ||
Depreciation/Fixed assets |
0.19 | 0.17 |
Cash ROIC |
8.05% | 2.45% |
Accounts Receivable Turnover |
0.00 | 18.02 |
Accounts Payable Turnover |
0.00 | 12.84 |
Inventory Turnover |
0.00 | 10.29 |
Average Days of Payables |
30.41 | 30.21 |
Days of Inventory on Hand |
36.86 | 38.67 |
Average Receivables |
— | 4,781.93 |
Average Payables |
— | 5,831.81 |
Average Inventory |
— | 7,279.07 |
Average Assets |
— | 42,920.93 |
Average Common Equity |
— | 8,828.58 |
Columns are period end dates